Treating tumours of the ampulla of Vater requires a careful approach tailored to each patient’s situation. The goals often include removing the cancer when possible, relieving symptoms like jaundice, and maintaining quality of life. Medical teams consider how advanced the cancer is, the patient’s overall health, and whether the tumour can be safely removed through surgery. Both established surgical methods and emerging therapies tested in research studies play important roles in managing this rare digestive cancer.

Understanding Treatment Goals for Ampullary Tumours

When someone receives a diagnosis of ampullary cancer, the immediate focus turns to finding the best way to address this rare condition. The ampulla of Vater sits at a critical junction where digestive juices from the liver and pancreas meet before entering the small intestine. Because this cancer forms so close to vital digestive organs, treatment decisions must account for both removing the cancer and protecting surrounding structures^[1].

Treatment planning begins with understanding how far the cancer has spread. The stage of the disease—meaning whether it remains confined to the ampulla or has reached nearby tissues, lymph nodes, or distant organs—heavily influences what treatments doctors recommend. Patients with cancer that has not spread beyond the ampulla typically have more treatment options available, including curative surgery. However, even when the cancer has advanced, medical teams can offer treatments aimed at controlling symptoms and extending life^[2].

Medical societies and cancer centres follow established guidelines for treating ampullary cancer, though these guidelines often borrow from recommendations for related cancers affecting the pancreas, bile ducts, and small intestine. This happens because ampullary cancer is so uncommon that large-scale studies specifically focused on it are difficult to conduct. Researchers continue working to develop better treatments through clinical trials, which test new drugs and treatment combinations that might improve outcomes for patients^[5].

Standard Surgical Treatment

Surgery remains the cornerstone of treatment for ampullary cancer when the tumour can be completely removed. The most common operation is called pancreaticoduodenectomy, often referred to as the Whipple procedure. This complex surgery involves removing the head of the pancreas, part of the small intestine, the gallbladder, part of the bile duct, and sometimes a portion of the stomach. Surgeons then reconnect the remaining digestive organs so that food can pass through normally and digestive juices can reach the intestine^[10].

For carefully selected patients with very small tumours that have not invaded deeply, a less extensive operation called local excision might be possible. During this procedure, surgeons remove only the tumour and a small amount of surrounding tissue, often using an endoscope—a thin tube with a camera inserted through the mouth. This approach preserves more of the digestive system but is only suitable for early-stage cancers that meet specific criteria^[15].

During any cancer surgery, the surgical team also removes nearby lymph nodes—small bean-shaped structures that filter fluid and can harbour cancer cells. Examining these lymph nodes under a microscope helps determine whether the cancer has spread beyond the ampulla. If cancer cells appear in the lymph nodes, doctors typically recommend additional treatments after surgery to reduce the risk of the cancer returning^[8].

Five-year survival rates after surgery vary widely depending on the stage of disease. Patients whose cancer was detected early and completely removed may have survival rates between 40% and 75%, while those with more advanced disease at the time of surgery face more challenging outcomes. These statistics represent averages from large groups of patients and cannot predict what will happen to any individual person^[11].

Not everyone with ampullary cancer can undergo surgery. If the tumour has spread to the liver, wrapped around major blood vessels, or metastasised to distant parts of the body, attempting to remove it surgically may cause more harm than good. In these situations, doctors focus on other treatment approaches that can control the cancer’s growth and manage symptoms^[15].

Chemotherapy Following Surgery

After surgical removal of ampullary cancer, many patients receive adjuvant therapy—additional treatment designed to destroy any cancer cells that might remain in the body. The role of adjuvant therapy for ampullary cancer continues to be debated among cancer specialists because strong evidence supporting its benefit is limited^[11].

Chemotherapy uses drugs that travel through the bloodstream to reach cancer cells throughout the body. One commonly used drug is 5-fluorouracil, which interferes with cancer cells’ ability to make new DNA, preventing them from multiplying. Another option is capecitabine, a pill form of chemotherapy that the body converts into 5-fluorouracil. These drugs may be given alone or combined with other chemotherapy agents^[15].

Some treatment centres combine chemotherapy with radiation therapy, which uses high-energy beams to kill cancer cells in specific areas of the body. This approach, called chemoradiation, may be particularly useful for patients whose cancer had spread to nearby lymph nodes or whose tumour showed concerning features when examined under the microscope. Radiation doses typically range from 40 to 50 gray units delivered over several weeks, with chemotherapy given at the same time to make the radiation more effective^[15].

Chemotherapy can cause side effects that vary depending on which drugs are used and how much is given. Common effects include fatigue, nausea, diarrhoea, reduced appetite, and increased risk of infections due to lower white blood cell counts. Most side effects improve after treatment ends, and medical teams have many strategies to help patients manage these symptoms during therapy^[10].

Treatment for Advanced or Unresectable Disease

When ampullary cancer cannot be removed with surgery—either because it has spread too far or because the patient’s other health conditions make surgery too risky—treatment focuses on slowing the cancer’s growth and relieving symptoms. This is called palliative care, though the term does not mean giving up; rather, it represents a shift in goals toward maintaining the best possible quality of life^[16].

Chemotherapy remains an important option for advanced ampullary cancer. Studies have explored different drug combinations, including gemcitabine, a chemotherapy drug often used for pancreatic and bile duct cancers. Another combination called CAPOX uses capecitabine together with oxaliplatin, a platinum-based drug. In research studies involving patients with advanced ampullary cancer, CAPOX showed promising results with overall survival reaching approximately 20 months^[15].

Because ampullary cancer shares features with cancers of the colon, pancreas, and bile ducts, doctors sometimes adapt treatment approaches from these more common cancers. The specific treatment plan depends partly on what the cancer looks like under the microscope. Ampullary cancers can be classified into subtypes based on their appearance, with the pancreaticobiliary subtype generally behaving more aggressively than the intestinal subtype. Knowing the subtype helps guide treatment choices^[5].

For patients experiencing jaundice—yellowing of the skin and eyes caused by blocked bile flow—doctors can perform procedures to restore drainage even without removing the cancer. One approach uses an endoscope to place a small tube called a stent inside the blocked bile duct, allowing bile to flow into the intestine again. This relieves itching, improves digestion, and can make patients feel significantly better^[8].

Exploring New Treatments in Clinical Trials

Clinical trials represent an important avenue for patients with ampullary cancer to access innovative treatments that are not yet widely available. These research studies carefully test new drugs, treatment combinations, or approaches to determine whether they are safe and effective. Participating in a clinical trial gives patients access to cutting-edge therapies while helping scientists gather information that could benefit future patients^[7].

Researchers are investigating the molecular features of ampullary cancer to identify specific abnormalities that might be targeted with new drugs. Studies have found that many ampullary cancers carry mutations—changes in genes—affecting pathways that control cell growth and division. Common mutations involve genes called KRAS, TP53, and SMAD4. Understanding which mutations are present in a patient’s tumour could eventually help doctors select treatments most likely to work for that individual^[5].

Immunotherapy represents another area of active investigation. These treatments work by helping the patient’s own immune system recognise and attack cancer cells. Some ampullary cancers have features called microsatellite instability or high levels of proteins that suppress immune responses. Tumours with these characteristics might respond to immunotherapy drugs, though research in this area is still developing^[5].

Some clinical trials test whether giving chemotherapy or chemoradiation before surgery—called neoadjuvant therapy—can shrink tumours and make them easier to remove completely. A small study reported that four patients who received neoadjuvant chemoradiation for ampullary cancer had no remaining tumour visible when the surgical specimens were examined after the operation. While these results are encouraging, larger studies are needed to determine whether this approach improves long-term outcomes^[15].

Clinical trials for ampullary cancer are conducted at major cancer centres in the United States, Europe, and other regions. Because ampullary cancer is rare, finding enough patients to participate in studies can be challenging. Doctors often encourage patients to consider travelling to specialised centres that have active research programs. Patients interested in clinical trials should discuss this option with their medical team, who can help identify appropriate studies and explain what participation would involve^[7].

The future of ampullary cancer treatment likely lies in understanding the molecular and genetic features of each individual’s tumour and selecting therapies based on these characteristics. This approach, called precision medicine or personalised medicine, is gradually becoming more common in cancer care. As researchers identify more targets for treatment and develop drugs that hit those targets specifically, options for patients with ampullary cancer should continue to expand^[11].

Most common treatment methods

• Surgical procedures
  • Pancreaticoduodenectomy (Whipple procedure) – removal of the pancreas head, part of the small intestine, gallbladder, and bile duct
  • Local excision – removal of small, early-stage tumours through an endoscope
  • Systematic lymphadenectomy – removal of nearby lymph nodes to check for cancer spread
• Chemotherapy
  • 5-fluorouracil – interferes with cancer cell DNA production
  • Capecitabine – oral chemotherapy converted to 5-fluorouracil in the body
  • Oxaliplatin – platinum-based drug often combined with capecitabine (CAPOX regimen)
  • Gemcitabine – used particularly for pancreaticobiliary subtype tumours
• Radiation therapy
  • External beam radiation (40-50 Gray) often combined with chemotherapy
  • Chemoradiation for high-risk features or lymph node involvement
• Palliative procedures
  • Endoscopic stent placement to relieve bile duct blockage and jaundice
  • Symptom management treatments for advanced disease
• Clinical trial approaches
  • Neoadjuvant therapy – chemotherapy or chemoradiation before surgery
  • Immunotherapy for tumours with microsatellite instability
  • Targeted therapies based on molecular features and gene mutations